CURE vs SPY
5Y+29.9%3 years · per year$21,930 · $18,174+22.0%
+7.9%5 years · per year$14,647 · $17,099+11.3%
0.94%Expense ratio$94 · $9 on $10k · lower wins0.09%
0.76%12-mo yield$76 · $103 on $10k1.03%
−31.1%Worst dropSmaller wins−8.9%
49.4%VolatilityLower wins13.6%
1–5SPY wins
$10,000 · 5 yearsOne scale
Shared top holdingsCURE · SPY
3.3%LLY1.7%
1.9%JNJ1.0%
1.5%ABBV0.8%
1.1%MRK0.6%
Held in common10.4%
End-of-day Nov 5, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two